Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer.
暂无分享，去创建一个
E. Van Cutsem | G. Bodoky | M. Bass | M. Valladares-Ayerbes | N. Tebbutt | N. Nanayakkara | A. Adewoye | C. Bampton | Z. D. Zhong | A. Strickland | Y-N Sun | M. Eatock | A. Świeboda-Sadlej | E. Cutsem | Y. Sun